The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,227,723 in first-year total cost, median $253,111.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]9
- Special Emphasis Panel[ZAR1 KS (M2)]2
- Special Emphasis Panel[ZAR1 FY (M2)]1
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- CINCINNATI CHILDRENS HOSP MED CTR1
- GEORGE WASHINGTON UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- LURIE CHILDREN'S HOSPITAL OF CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection1R34AR075304-01A1 | CHANG, AILEEN | GEORGE WASHINGTON UNIVERSITY, DC | $351,997 | AMSC |
| 2020 | Longterm Effect Of Genicular Nerve Ablation on Knee Pain, Gait and Joint Structure1R34AR076625-01A1 | MCALINDON, TIMOTHY E | TUFTS MEDICAL CENTER, MA | $324,447 | AMSC |
| 2020 | Preventing Incident Knee Osteoarthritis: The Osteoarthritis Prevention Study (TOPS)1R34AR077361-01 | MESSIER, STEPHEN P | WAKE FOREST UNIVERSITY, NC | $254,373 | ZAR1 |
| 2020 | Planning for a Trial of Comparative Effectiveness of Gout Management Strategies1R34AR076077-01A1 | BARRY, MICHAEL JCHOI, HYON KSOLOMON, DANIEL HAL | MASSACHUSETTS GENERAL HOSPITAL, MA | $239,567 | ZAR1 |
| 2019 | IMPACCT – Infrastructure for Musculoskeletal Pediatric Acute Care Clinical Trials1R34AR075303-01 | JANICKI, JOSEPH A | LURIE CHILDREN'S HOSPITAL OF CHICAGO, IL | $335,708 | AMSC |
| 2019 | Prospective Comparison of BioJoints versus Total and Unicompartmental Knee Arthroplasty1R34AR074209-01A1 | COOK, JAMES LSTANNARD, JAMES P | UNIVERSITY OF MISSOURI-COLUMBIA, MO | $272,800 | AMSC |
| 2019 | Withdrawal of Hydroxychloroquine in Elderly Lupus Patients: Planning Grant1R34AR075283-01 | BUYON, JILL PIZMIRLY, PETER | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $266,753 | ZAR1 |
| 2019 | Cell-Based Autogenous Grafting for the Treatment of Femoral Head Osteonecrosis1R34AR073505-01A1 | GOODMAN, STUART BJONES, LYNNE C.MONT, MICHAEL | JOHNS HOPKINS UNIVERSITY, MD | $251,848 | AMSC |
| 2019 | Comparative effectiveness of spironolactone versus oral tetracycline-class antibiotics for the treatment of moderate to severe acne in women1R34AR074733-01A1 | MARGOLIS, DAVID | UNIVERSITY OF PENNSYLVANIA, PA | $249,480 | AMSC |
| 2018 | Improving Pediatric Lupus Nephritis Through Personalized Mycophenolate Mofetil Therapy1R34AR071651-01A1 | BRUNNER, HERMINE IVINKS, ALEXANDER A | CINCINNATI CHILDRENS HOSP MED CTR, OH | $244,860 | AMSC |
| 2018 | Combination Osteoporosis Therapy and Fracture Reduction1R34AR074114-01 | LEDER, BENJAMIN Z | MASSACHUSETTS GENERAL HOSPITAL, MA | $235,250 | AMSC |
| 2018 | Planning Grant for an Intensive Weight Loss Clinical Trial for Overweight and Obese Patients Post Total Knee Replacement1R34AR074066-01 | MIHALKO, WILLIAM MRICHEY, PHYLLIS A | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $200,640 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.